Ecto-5’-nucleotidase CD73 modulates the innate immune response to influenza infection but is not required for development of influenza-induced acute lung injury

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 309, Issue 11, 2015, Pages L1313-L1322

  Aeffner, Famke ^a   Wood, Parker S ^a   Davis, Ian C ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Acute lung injury; Adenosine; CD73; Influenza; Mouse

Indexed keywords

5' NUCLEOTIDASE; ALPHA,BETA METHYLENEADENOSINE DIPHOSPHATE; CXCL1 CHEMOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; 5'-ADENYLYL (BETA,GAMMA-METHYLENE)DIPHOSPHONATE; ADENOSINE TRIPHOSPHATE; ALKALINE PHOSPHATASE; ALKALINE PHOSPHATASE 2, MOUSE; CHEMOKINE; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; NT5E PROTEIN, MOUSE;

ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRADYCARDIA; BRONCHOCONSTRICTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; GENE INACTIVATION; HYPOXEMIA; IMMUNOMODULATION; INFLUENZA A (H1N1); INNATE IMMUNITY; LUNG DISEASE; LUNG EDEMA; LUNG LAVAGE; MOUSE; NEUTROPHIL COUNT; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; VIRUS REPLICATION; WEIGHT REDUCTION; WILD TYPE; ANALOGS AND DERIVATIVES; ANIMAL; BRONCHOALVEOLAR LAVAGE FLUID; C57BL MOUSE; COMPLIANCE (PHYSICAL); COMPLICATION; CYTOLOGY; DRUG EFFECTS; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; HEART; HUMAN; IMMUNOLOGY; INFLUENZA; INFLUENZA A VIRUS (H1N1); KNOCKOUT MOUSE; LEUKOCYTE COUNT; LUNG; METABOLISM; NEUTROPHIL; ORTHOMYXOVIRUS INFECTION; PATHOLOGY; PATHOPHYSIOLOGY; PULMONARY EDEMA; VIROLOGY;

5'-NUCLEOTIDASE; ACUTE LUNG INJURY; ADENOSINE TRIPHOSPHATE; ALKALINE PHOSPHATASE; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CHEMOKINES; COMPLIANCE; GENE EXPRESSION REGULATION; GPI-LINKED PROTEINS; HEART; HUMANS; IMMUNITY, INNATE; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; LEUKOCYTE COUNT; LUNG; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUTROPHILS; ORTHOMYXOVIRIDAE INFECTIONS; PULMONARY EDEMA; VIRUS REPLICATION;

EID: 84949500785     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00130.2015     Document Type: Article

References (40)

1. Aeffner F, Abdulrahman B, Hickman-Davis JM, Janssen PM, Amer A, Bedwell DM, Sorscher EJ, Davis IC. Heterozygosity for the F508del mutation in the cystic fibrosis transmembrane conductance regulator anion channel attenuates influenza severity. J Infect Dis 208: 780-789, 2013.
2. Aeffner F, Bratasz A, Flaño E, Powell KA, Davis IC. Post-infection A77-1726 treatment improves cardiopulmonary function in H1N1 influenza-infected mice. Am J Respir Cell Mol Biol 47: 543-551, 2012.
3. Aeffner F, Woods PS, Davis IC. Activation of Aradenosine receptors promotes leukocyte recruitment to the lung and attenuates acute lung injury in mice infected with influenza A/WSN/33 (H1N1) virus. J Virol 88: 10214-10227, 2014.
4. Askovich PS, Sanders CJ, Rosenberger CM, Diercks AH, Dash P, Navarro G, Vogel P, Doherty PC, Thomas PG, Aderem A. Differential host response, rather than early viral replication efficiency, correlates with pathogenicity caused by influenza viruses. PLos One 8: e74863, 2013.
5. Bouma M, van der Wildenburg F, Buurman W. Adenosine inhibits cytokine release and expression of adhesion molecules by activated human endothelial cells. Am J Physiol Cell Physiol 271: C522-C529, 1996.
6. Buchet R, Millán JL, Magne D. Multisystemic functions of alkaline phosphatases. In: Phosphatase Modulators, edited by Millán JL. New York: Humana, 2013, p. 27-51.
7. Caruso M, Alamo A, Crisafulli E, Raciti C, Fisichella A, Polosa R. Adenosine signaling pathways as potential therapeutic targets in respiratory disease. Expert Opin Ther Targets 17: 761-772, 2013.
8. Chan KM, Delfert D, Junger KD. A direct colorimetric assay for Ca2+-stimulated ATPase activity. Anal Biochem 157: 375-380, 1986.
9. Clark N, Lynch J. Influenza: epidemiology, clinical features, therapy, prevention. Semin Respir Crit Care Med 32: 373-392, 2011.
10. Colgan SP, Eltzschig HK, Eckle T, Thompson LF. Physiological roles for ecto-5’-nucleotidase (CD73). Purinergic Signal 2: 351-360, 2006.
11. Davies J, Karmouty-Quintana H, Le TT, Chen N, Weng T, Luo F, Molina J, Moorthy B, Blackburn MR. Adenosine promotes vascular barrier function in hyperoxic lung injury. Physiol Rep 2: e12155, 2014.
12. Davis IC, Sullender WM, Hickman-Davis JM, Lindsey JR, Matalon S. Nucleotide-mediated inhibition of alveolar fluid clearance in BALB/c mice after respiratory syncytial virus infection. Am J Physiol Lung Cell Mol Physiol 286: L112-L120, 2004.
13. Davis IC, Xu A, Gao Z, Hickman-Davis JM, Factor P, Sullender WM, Matalon S. Respiratory syncytial virus induces insensitivity to ß-adren-ergic agonists in mouse lung epithelium in vivo. Am J Physiol Lung Cell Mol Physiol 293: L281-L289, 2007.
14. Dunwiddie TV, Diao L, Proctor WR. Adenine nucleotides undergo rapid, quantitative conversion to adenosine in the extracellular space in rat hippocampus. J Neurosci 17: 7673-7682, 1997.
15. García-Sastre A, Durbin RK, Zheng H, Palese P, Gertner R, Levy DE, Durbin JE. The role of interferon in influenza virus tissue tropism. J Virol 72: 8550-8558, 1998.
16. Gotts JE, Abbott J, Matthay MA. Influenza causes prolonged disruption of the alveolar-capillary barrier in mice unresponsive to mesenchymal stem cell therapy. Am J Physiol Lung Cell Mol Physiol 307: L395-L406, 2014.
17. Hamilton BE, Miniño AM, Martin JA, Kochanek KD, Strobino DM, Guyer B. Annual summary of vital statistics: 2005. Pediatrics 119: 345-360, 2007.
18. Hoegl S, Brodsky KS, Blackburn MR, Karmouty-Quintana H, Zwissler B, Eltzschig HK. Alveolar epithelial A2B-adenosine receptors in pulmonary protection during acute lung injury. J Immunol 195: 1815-1824, 2015.
19. Hofer CC, Woods PS, Davis IC. Infection of mice with influenza A/WSN/33 (H1N1) virus alters alveolar type II cell phenotype. Am J Physiol Lung Cell Mol Physiol 308: L628-L638, 2015.
20. Irvin CG, Bates JH. Measuring the lung function in the mouse: the challenge of size. Respir Res 4: 4-13, 2003.
21. Junger WG. Immune cell regulation by autocrine purinergic signalling. Nat Rev Immunol 11: 201-212, 2011.
22. Kreindler JL, Shapiro SD. Lung turns to AA (adenosine analogues) to dry out. Nat Med 13: 406-408, 2007.
23. Kunzelmann K, Konig J, Sun J, Markovich D, King NJ, Karupiah G, Young JA, Cook DI. Acute effects of parainfluenza virus on epithelial electrolyte transport. J Biol Chem 279: 48760-48766, 2004.
24. Kunzelmann K, Sun J, Meanger J, King NJ, Cook DI. Inhibition of airway Na+ transport by respiratory syncytial virus. J Virol 81: 3714-3720, 2007.
25. Matute-Bello G, Downey G, Moore BB, Groshong SD, Matthay MA, Slutsky AS, Kuebler WM, Acute Lung Injury in Animals Study Group. An official American Thoracic Society Workshop Report: features and measurements of experimental acute lung injury in animals. Am J Respir Cell Mol Biol 44: 725-738, 2011.
26. Mills JH, Thompson LF, Mueller C, Waickman AT, Jalkanen S, Niemela J, Airas L, Bynoe MS. CD73 is required for efficient entry of lymphocytes into the central nervous system during experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA 105: 9325-9330, 2008.
27. Picher M. Mechanisms regulating airway nucleotides. Subcell Biochem 55: 17-49, 2011.
28. Picher M, Burch LH, Hirsh AJ, Spychala J, Boucher RC. Ecto 5’-nucleotidase and nonspecific alkaline phosphatase. Two AMP-hydro-lyzing ectoenzymes with distinct roles in human airways. J Biol Chem 278: 13468-13479, 2003.
29. Reutershan J, Vollmer I, Stark S, Wagner R, Ngamsri KC, Eltzschig HK. Adenosine and inflammation: CD39 and CD73 are critical mediators in LPS-induced PMN trafficking into the lungs. FASEB J 23: 473-482, 2009.
30. Synnestvedt K, Furuta GT, Comerford KM, Louis N, Karhausen J, Eltzschig HK, Hansen KR, Thompson LF, Colgan SP. Ecto-5’-nucle-otidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia. J Clin Invest 110: 993-1002, 2002.
31. Tate MD, Pickett DL, Van Rooijen N, Brooks AG, Reading PC. Critical role of airway macrophages in modulating disease severity during influenza virus infection of mice. J Virol 84: 7569-7580, 2010.
32. Taubenberger JK, Morens DM. Influenza: the once and future pandemic. Public Health Rep 125 Suppl 3: 16-26, 2010.
33. Thompson LF, Eltzschig HK, Ibla JC, Van De Wiele CJ, Resta R, Morote-Garcia JC, Colgan SP. Crucial role for ecto-5’-nucleotidase (CD73) in vascular leakage during hypoxia. J Exp Med 200: 1395-1405, 2004.
34. Tong HH, Long JP, Li D, DeMaria TF. Alteration of gene expression in human middle ear epithelial cells induced by influenza A virus and its implication for the pathogenesis of otitis media. Microb Pathog 37: 193-204, 2004.
35. Traylor ZP, Aeffner F, Davis IC. Influenza A H1N1 induces declines in alveolar gas exchange in mice consistent with rapid post-infection progression from acute lung injury to ARDS. Influenza Other Respir Viruses 7: 472-479, 2013.
36. Webster RG, Govorkova EA. Continuing challenges in influenza. Ann NYAcadSci 1323: 115-139, 2014.
37. Wink MR, Lenz G, Braganhol E, Tamajusuku AS, Schwartsmann G, Sarkis JJ, Battastini AM. Altered extracellular ATP, ADP and AMP catabolism in glioma cell lines. Cancer Lett 198: 211-218, 2003.
38. Wolk KE, Lazarowski ER, Traylor ZP, Yu EN, Jewell NA, Durbin RK, Durbin JE, Davis IC. Influenza A virus inhibits alveolar fluid clearance in BALB/c mice. Am J Respir Crit Care Med 178: 969-976, 2008.
39. Yegutkin GG. Enzymes involved in metabolism of extracellular nucleo-tides and nucleosides: functional implications and measurement of activities. Crit Rev Biochem Mol Biol 49: 473-497, 2014.
40. Zimmermann H, Zebisch M, Sträter N. Cellular function and molecular structure of ecto-nucleotidases. Purinergic Signal 8: 437-502, 2012.